66th ASH Annual Meeting: How Do We Effectively Capture Adverse Events, Particularly Infections Post Hematopoietic Stem Cell Transplantation?

Symposia: Scientific Workshop on Genomic Toxicities of Gene and Cell Therapies Scientific Workshops

Room 31 (San Diego Convention Center)

Moderators:

Matthew Hsieh, MD, NIH-NHLBI-MCHB and Rayne Rouce, MD, Clinical Care Center-Texas Children's Hospital

Disclosures:

Rouce: Pfizer: Consultancy; Novartis: Honoraria.

We will conclude with a discussion focused on the beneﬁts and limitations of current systems of adverse event monitoring, with the aim of engaging regulatory agencies to design more eﬀective approaches.

Moderator Introduction (Classical Hematology Perspective)

Matthew Hsieh, MD

NHLBI, NIH-NHLBI-MCHB, Bethesda, MD

Moderator Introduction (Malignant Hematology Perspective)

Rayne Rouce, MD

Clinical Care Center-Texas Children's Hospital, Houston, TX

Benign Diseases

Adetola A. Kassim, MBBS, MS

Vanderbilt University Medical Center, Nashville, TN

Malignant Diseases

Kathryn Cappell, MD, PhD

National Institutes of Health, Bethesda, MD

Panel Discussion

See more of: Scientific Workshop on Genomic Toxicities of Gene and Cell Therapies
See more of: Scientific Workshops

<< Previous Session | Next Session >>